What We Offer

Theranostics Development & Target Diseases


Early diagnosis is the key to improving survival and finding cure for variety of lung conditions such as Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Idiopathic Pulmonary Fibrosis (IPF) etc. In addition, exposure to biomass smoke, cigarette smoke, e-cigarette vapors and air pollution triggers chronic lung conditions where development of LungHealth Diagnostics will allow early prognosis based intervention.


Age-related neurodegenerative conditions and macular degenration (AMD) as well as smoke induced accelerated lung aging invlove changes in cellular homeostatic processes that serves as early prognostic indicators of initiation of disease for timely intervention. Thus, development of prognosis based intervention provides a novel intervention strategy for age-realted disorders.


Targeted patient specifc therapies for acquired dysfunctions and/or inherent genetic factors, allowing early intervention for susceptible subjects as well as increasing the efficacy of treatment while avoiding adverse side effects. As an example, variety of restrictive lung conditions involves susceptibility factors that trigger or flare up disease on exposure to envioronmental or biomass smoke and aging etc, where early screening and targeted intervention can help improve survival.


Slogan / Motto

Innovative prognosis based early intervention is a key to improving survival and cure chronic or fatal diseases.

Mission Statement

PRECISION THERANOSTICS is focused on development of novel diagnostics, therapeutics and prognosis based therapies for improving survival and finding cure for chronic repisratory diseases and age-related disorders.